Download presentation
Presentation is loading. Please wait.
Published byFrançois-Xavier Lemieux Modified over 6 years ago
1
Volume 60, Issue 5, Pages 908-916 (November 2011)
Late Gastrointestinal Toxicities Following Radiation Therapy for Prostate Cancer Sung Kim, Shunhua Shen, Dirk F. Moore, Weichung Shih, Yong Lin, Hui Li, Matthew Dolan, Yu-Hsuan Shao, Grace L. Lu-Yao European Urology Volume 60, Issue 5, Pages (November 2011) DOI: /j.eururo Copyright © Terms and Conditions
2
Fig. 1 Cumulative incidence estimates of any gastrointestinal (GI) toxicity by treatment group. Competing risk was computed by using cumulative incidence adjusting for death from any cause prior to any GI toxicity. European Urology , DOI: ( /j.eururo ) Copyright © Terms and Conditions
3
Fig. 2 Cumulative incidence estimates of any gastrointestinal (GI) toxicity by radiation modality. Competing risk was computed by using cumulative incidence adjusting for death from any cause prior to any GI toxicity. 3D CRT=three-dimensional conformal radiotherapy; Brachy=brachytherapy; IMRT=intensity-modulated radiotherapy; Proton=proton beam therapy. European Urology , DOI: ( /j.eururo ) Copyright © Terms and Conditions
4
Fig. 3 (a) Cumulative incidence estimates of any gastrointestinal (GI) toxicity by year of cancer diagnosis for proton-treated patients. Competing risk was computed by using cumulative incidence adjusting for death from any causes prior to any GI toxicity. (b) Cumulative incidence estimates of any GI toxicity by year of cancer diagnosis for patients treated with intensity-modulated radiotherapy. Competing risk was computed by using cumulative incidence adjusting for death from any causes before any GI toxicity. European Urology , DOI: ( /j.eururo ) Copyright © Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.